Espace adhérents

03/02/2017 15th Afipa barometer of selfcare products

Paris, 03 February 2017 - Afipa (French Federation of the Pharmaceutical Industry for Responsible Self-Medication) presents the results of the 15th barometer of selfcare products, conducted in collaboration with OpenHealth.

16/06/2016 AFIPA IS IN BATTLE ORDER TO INCREASE SELF-MEDICATION AWARENESS AMONG THE FRENCH PEOPLE

Afipa (French Federation of the Pharmaceutical Industry for Responsible Self-Medication) has decided to actively promote self-medication awareness, due to the lack of political initiative on this crucial topic

From June 20th to July 1st, 2016, Afipa will host “My Health My Choice: A Minute A Day To Responsibly Self-Medicate” 


16/06/2016 Dominique Giulini is elected President of AFipa

Paris, June 16th, 2016 - Dominique Giulini has been elected President of Afipa (French Federation of the Pharmaceutical Industry for Responsible Self-Medication) by the Board of Directors. 


16/03/2016 - Ipsos survey - The French people, the general practitioners and responsible self-medication


16/03/2016 Survey on economic impact resulting from the updating of switches and de-reimbursement


15/03/2016 Manifest for the development of selfcare in France


22/01/2016 14th Afipa Barometer on selfcare products : selfcare continues its progression in 2015 as an essential part of the health care system

Paris, January 22nd 2016 : Afipa (French Federation of the Pharmaceutical Industry for Responsible Self-Medication) presents the results of the 14th barometer on selfcare products, conducted in collaboration with OpenHealth

23/06/2015 3rd European Observatory on self-medication

Paris, 23 June 2015 – AFIPA, the French Federation of the Pharmaceutical Industry for Responsible Self-Medication, has published the third edition of the European Observatory on Self-Medication. This analysis, carried out by Celtipharm, provides an overview and comparison of the situation with respect to self-medication in 8 European countries (France, Germany, Belgium, Netherlands, Spain, Italy, Sweden and the UK) on the basis of several criteria and indicators. 

This year, AFIPA focused in particular on European healthcare systems. According to the analysis, Spain has emerged as a positive example for France.
To view the detailed results of this study and read the corresponding press release 

20/01/2015 - 13th Afipa Barometer on selfcare products: the self-medication sector is recovering but political support is still lacking

On 20 January 2015, AFIPA (the French Federation of the Pharmaceutical Industry for Responsible Self-Medication) presented the 13th Barometer on Selfcare Products, prepared in conjunction with Celtipharm.

Despite results that were positive overall, the market remains fragile and needs the support of a genuine healthcare strategy from the public authorities. That need is all the more critical given that the market turnaround in December has clearly proved the effectiveness of the healthcare model advocated by AFIPA.

Below you will find the press release.


11/09/2014 - Repeated criticism of self-medication drug prices is unjustified

Retail pharmacies currently face a negative environment, characterised by too frequent attacks on the price of self-medication drugs. In that context, and following continued allegations in the Report of the French Inspectorate General of Finances – the conclusions of which do not correspond to the findings of Afipa’s own studies – Afipa is keen to reiterate a number objective and verifiable facts.

To read the press release: 

24/06/2014 - 2nd European Observatory on self-medication : the French spend less than €3 per month on self-medication

For the second consecutive year, AFIPA has released the European Observatory on Self-Medication. The study, conducted by Celtipharm, sets out and compares the self-medication landscape in 8 European countries (France, Germany, Belgium, the Netherlands, Spain, Italy, Sweden and the United Kingdom [EU 8]) on the basis of an assessment of a range of criteria and indicators. 
To view the detailed results of this study and read the corresponding press release : 

22/01/2014 - 12th Afipa Barometer on selfcare products : An imbalanced and contrasted situation for products in the selfcare market

Reflecting AFIPA’s shift towards selfcare products (medicines, medical devices and self-medication food supplements)[1], AFIPA (the French Federation of the Pharmaceutical Industry for Responsible Self-Medication) has for the first time published the 2013 figures for this market. Carried out by Celtipharm, the 12th Barometer shows an imbalance between self-medication drugs on the one hand and medical devices and food supplements on sale in pharmacies on the other.

Total sales of self-medication drugs, at retail price and including VAT, amounted to €2.123 billion in 2013, a 3% decline compared to 2012. In contrast, medical devices and food supplements experienced more favourable conditions, with an increase in sales of 4.3% and 6.2% respectively.

[1] The selfcare products represented by Afipa are aimed at individuals who wish to play a role in their own health care or well-being, generally speaking with the advice of a health care professional. They include medicines for which a medical prescription is optional and which are not reimbursed, medical devices (for which a prescription is optional or unnecessary and which are not reimbursed) and food supplements (available without a prescription).

To read the press release :